Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 5 | 2020 | 89 | 2.070 |
Why?
|
| Physical Endurance | 5 | 2021 | 91 | 1.950 |
Why?
|
| Resistance Training | 7 | 2020 | 212 | 1.460 |
Why?
|
| Muscle Strength | 7 | 2019 | 230 | 1.440 |
Why?
|
| Muscle, Skeletal | 11 | 2020 | 639 | 1.340 |
Why?
|
| Leg | 5 | 2019 | 134 | 1.210 |
Why?
|
| Exercise Test | 8 | 2021 | 249 | 1.170 |
Why?
|
| Lactates | 2 | 2018 | 20 | 1.100 |
Why?
|
| Oxygen Consumption | 10 | 2026 | 189 | 1.040 |
Why?
|
| Basal Metabolism | 1 | 2026 | 11 | 0.980 |
Why?
|
| Calorimetry, Indirect | 1 | 2026 | 15 | 0.980 |
Why?
|
| Masks | 1 | 2026 | 11 | 0.970 |
Why?
|
| Exercise | 8 | 2023 | 497 | 0.950 |
Why?
|
| Muscle Fatigue | 2 | 2022 | 77 | 0.830 |
Why?
|
| Bicycling | 3 | 2019 | 41 | 0.820 |
Why?
|
| Mouthwashes | 1 | 2022 | 4 | 0.730 |
Why?
|
| Shoes | 1 | 2021 | 9 | 0.710 |
Why?
|
| Running | 1 | 2021 | 39 | 0.700 |
Why?
|
| Foot | 1 | 2021 | 23 | 0.700 |
Why?
|
| H-Reflex | 1 | 2020 | 4 | 0.660 |
Why?
|
| Male | 25 | 2026 | 13921 | 0.620 |
Why?
|
| Adult | 21 | 2026 | 8024 | 0.610 |
Why?
|
| Young Adult | 14 | 2026 | 2833 | 0.560 |
Why?
|
| Humans | 29 | 2026 | 28851 | 0.540 |
Why?
|
| Lower Extremity | 2 | 2017 | 85 | 0.490 |
Why?
|
| Exercise Therapy | 2 | 2014 | 84 | 0.490 |
Why?
|
| Athletes | 3 | 2021 | 70 | 0.460 |
Why?
|
| Physical Fitness | 1 | 2015 | 62 | 0.440 |
Why?
|
| Adiposity | 1 | 2015 | 94 | 0.430 |
Why?
|
| Female | 17 | 2026 | 15624 | 0.420 |
Why?
|
| Exercise Tolerance | 1 | 2014 | 82 | 0.390 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2013 | 21 | 0.390 |
Why?
|
| Walking | 1 | 2013 | 136 | 0.350 |
Why?
|
| Chronic Pain | 2 | 2022 | 62 | 0.340 |
Why?
|
| Aging | 2 | 2015 | 1016 | 0.330 |
Why?
|
| Cerebrovascular Circulation | 2 | 2023 | 224 | 0.320 |
Why?
|
| Case-Control Studies | 3 | 2019 | 739 | 0.310 |
Why?
|
| Body Composition | 4 | 2022 | 267 | 0.310 |
Why?
|
| Adolescent | 8 | 2020 | 3193 | 0.270 |
Why?
|
| Regional Blood Flow | 6 | 2020 | 164 | 0.260 |
Why?
|
| Middle Aged | 8 | 2019 | 7414 | 0.260 |
Why?
|
| Torque | 2 | 2018 | 91 | 0.250 |
Why?
|
| Time Factors | 5 | 2017 | 1613 | 0.240 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 787 | 0.230 |
Why?
|
| Isometric Contraction | 3 | 2022 | 119 | 0.220 |
Why?
|
| Muscle Contraction | 2 | 2016 | 171 | 0.220 |
Why?
|
| Physical Exertion | 2 | 2015 | 104 | 0.200 |
Why?
|
| Heart Rate | 2 | 2021 | 382 | 0.190 |
Why?
|
| Blood Pressure | 3 | 2023 | 357 | 0.190 |
Why?
|
| Pain Perception | 1 | 2022 | 17 | 0.190 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2017 | 75 | 0.180 |
Why?
|
| Carbohydrates | 1 | 2022 | 17 | 0.180 |
Why?
|
| Electromyography | 2 | 2020 | 176 | 0.180 |
Why?
|
| Absorptiometry, Photon | 3 | 2020 | 101 | 0.180 |
Why?
|
| Fatigue | 1 | 2022 | 64 | 0.170 |
Why?
|
| High-Intensity Interval Training | 1 | 2020 | 9 | 0.170 |
Why?
|
| Postural Balance | 1 | 2020 | 41 | 0.160 |
Why?
|
| Adaptation, Physiological | 2 | 2018 | 173 | 0.160 |
Why?
|
| Weight-Bearing | 2 | 2017 | 43 | 0.160 |
Why?
|
| Research Design | 1 | 2021 | 187 | 0.160 |
Why?
|
| Soccer | 1 | 2020 | 50 | 0.150 |
Why?
|
| Bone Density | 1 | 2020 | 101 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2020 | 173 | 0.150 |
Why?
|
| Age Factors | 3 | 2015 | 737 | 0.150 |
Why?
|
| Thigh | 2 | 2015 | 39 | 0.140 |
Why?
|
| Evoked Potentials, Motor | 1 | 2018 | 22 | 0.140 |
Why?
|
| Quadriceps Muscle | 1 | 2018 | 61 | 0.140 |
Why?
|
| Femoral Artery | 1 | 2017 | 58 | 0.130 |
Why?
|
| Weight Lifting | 1 | 2017 | 49 | 0.130 |
Why?
|
| Microcirculation | 1 | 2017 | 113 | 0.130 |
Why?
|
| Microvessels | 1 | 2017 | 86 | 0.130 |
Why?
|
| Disability Evaluation | 2 | 2014 | 54 | 0.120 |
Why?
|
| Performance-Enhancing Substances | 1 | 2016 | 4 | 0.120 |
Why?
|
| Myalgia | 1 | 2016 | 20 | 0.120 |
Why?
|
| Caffeine | 1 | 2016 | 39 | 0.120 |
Why?
|
| Ischemia | 1 | 2016 | 83 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2016 | 94 | 0.120 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2015 | 11 | 0.110 |
Why?
|
| Vascular Stiffness | 1 | 2015 | 41 | 0.110 |
Why?
|
| Sarcopenia | 1 | 2015 | 44 | 0.110 |
Why?
|
| Oxygen | 1 | 2016 | 237 | 0.110 |
Why?
|
| Linear Models | 1 | 2015 | 202 | 0.110 |
Why?
|
| Perception | 1 | 2015 | 90 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 50 | 0.110 |
Why?
|
| Muscle, Striated | 1 | 2014 | 3 | 0.110 |
Why?
|
| Mitochondria, Muscle | 1 | 2013 | 44 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 334 | 0.100 |
Why?
|
| Pain Threshold | 2 | 2022 | 89 | 0.090 |
Why?
|
| Aged | 3 | 2015 | 5598 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2065 | 0.080 |
Why?
|
| Neoplasms | 1 | 2016 | 874 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2016 | 243 | 0.060 |
Why?
|
| Blood Flow Velocity | 1 | 2023 | 66 | 0.050 |
Why?
|
| Middle Cerebral Artery | 1 | 2023 | 54 | 0.050 |
Why?
|
| Hyperalgesia | 1 | 2022 | 16 | 0.050 |
Why?
|
| Ice | 1 | 2022 | 9 | 0.050 |
Why?
|
| Rest | 1 | 2023 | 96 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2022 | 274 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 2020 | 18 | 0.040 |
Why?
|
| Tibia | 1 | 2020 | 39 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2020 | 221 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 129 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 467 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2018 | 256 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2018 | 182 | 0.030 |
Why?
|
| Myoglobin | 1 | 2017 | 34 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2017 | 115 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2017 | 118 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 151 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 995 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 63 | 0.030 |
Why?
|
| Survivors | 1 | 2016 | 40 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 118 | 0.030 |
Why?
|
| Pulse Wave Analysis | 1 | 2015 | 30 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2015 | 27 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 88 | 0.030 |
Why?
|
| Arm | 1 | 2015 | 37 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 93 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 46 | 0.030 |
Why?
|
| Intermediate Filaments | 1 | 2014 | 1 | 0.030 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 8 | 0.030 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2014 | 16 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 82 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2016 | 422 | 0.030 |
Why?
|
| Axons | 1 | 2014 | 30 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 52 | 0.030 |
Why?
|
| Motor Neurons | 1 | 2014 | 44 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 1032 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 391 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2014 | 202 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 465 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2014 | 214 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 776 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 1653 | 0.020 |
Why?
|
| Mice | 1 | 2014 | 4802 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 10684 | 0.010 |
Why?
|